FOXA1 and Familial prostate cancer: (ii) More specifically, we demonstrate that a new androgen-dependent enhancer in one of the prostate cancer risk regions is functionally influenced by a risk-associated single nucleotide polymorphism (SNP) via differential FoxA1 binding.